Loratadine by Chain Drug Marketing Association Inc.
Dosage form: tablet, orally disintegrating
Ingredients: LORATADINE 10mg
Labeler: Chain Drug Marketing Association Inc.
NDC Code: 63868-157
Loratadine, USP 10 mg
Antihistamine
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
- runny nose
- itchy, watery eyes
- sneezing
- itching of the nose or throat
If you have ever had an allergic reaction to this product or any of its ingredients.
Liver or kidney disease. Your doctor should determine if you need a different dose.
Do not take more than directed. Taking more than directed may cause drowsiness.
An allergic reaction to this product occurs. Seek medical help right away.
Ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
- place 1 tablet on tongue; tablet disintegrates, with or without water
adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor
- Phenylketonurics: Contains Phenylalanine 0.6 mg Per Tablet.
- TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.
- store between 20° to 25° C (68° to 77° F). Protect from excessive moisture.
- keep in a dry place.
- use tablet immediately after opening individual blister.
Aspartame, croscarmellose sodium, fruit flavors, magnesium stearate, mannitol, sodium stearyl fumarate
Call 1-800-406-7984
QC QUALITY CHOICE®
NDC 63868-0157-10
†Compare to the active ingredient in Claritin® Reditabs®
NON-DROWSY٭٭
Original Prescription Strength
Allergy Relief
Loratadine Orally Disintegrating Tablets, 10 mg
Antihistamine
Indoor & Outdoor Allergies
No Water Needed · Melts in Your Mouth
For Adults and Children six years and older!
Relief of:
Sneezing; Runny Nose
Itchy, Watery Eyes; Itchy Throat or Nose
10 Orally Disintegrating Tablets
24 Hour
Allergy Relief
٭٭When taken as directed. See Drug Facts Panel.
©DISTRIBUTED BY QUALITY CHOICE
5079372/R0610
| LORATADINE
loratadine tablet, orally disintegrating |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
| Labeler - Chain Drug Marketing Association Inc. (011920774) |
| Registrant - Ranbaxy Pharmaceuticals Inc. (937890044) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Ohm Laboratories Inc. | 051565745 | manufacture(63868-157) | |
Medically reviewed on Sep 14, 2018
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
